Quantcast

Latest Amgen Stories

2014-11-11 16:25:45

Brodalumab Meets All Primary and All Key Secondary Endpoints THOUSAND OAKS, Calif. and LONDON, Nov.

2014-11-10 23:06:35

Mnemosyne appoints Vanessa King, Ph.D. Chief Executive Officer. Dr.

2014-11-10 08:34:30

THOUSAND OAKS, Calif., Nov. 10, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the U.S.

2014-11-06 16:36:17

THOUSAND OAKS, Calif., Nov. 6, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will participate at the Credit Suisse Annual Healthcare Conference on Tuesday, Nov.

2014-11-06 16:33:34

Presentations Including Pivotal Data on Kyprolis® and Blinatumomab, a BiTE® Immunotherapy, Demonstrate Company's Continued Commitment to Developing Treatments for Difficult-to-Treat Blood Cancers THOUSAND

2014-11-05 08:35:22

Board members to help Cloud Pharmaceuticals further penetrate the cloud-based drug design and development market RESEARCH TRIANGLE PARK, N.C., Nov.

2014-11-04 23:07:13

RnRMarketResearch.com adds “Colon Cancer and Ovarian Cancer – Pipeline Review, H2 2014” to its store.

2014-11-04 08:37:22

Study Failed to Meet Secondary Endpoint of Overall Survival THOUSAND OAKS, Calif., Nov.

2014-10-31 12:24:42

CHICAGO, Oct. 31, 2014 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog.

2014-10-28 16:27:34

Focusing development on rare autoimmune disorder IgG4-related disease (IgG4-RD) MONROVIA, Calif., Oct. 28, 2014 /PRNewswire/ -- Xencor, Inc.


Word of the Day
megalophonous
  • Having a loud voice; vociferous; clamorous.
  • Of grand or imposing sound.
The word 'megalophonous' comes from Greek roots meaning 'big' and 'sound'.